LCID
Lucid Group, Inc.
LCID has the edge over MTH overall, supported by stronger valuation and stronger modeled upside.
MTH
Meritage Homes Corporation
MTH has slightly lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MTH Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| Unavailable | |
| Under pressure |
MTH's profitability is currently stable, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.8x | $21.55 | -67% |
| Fair | 7.7x | $34.14 | -47% |
| Expensive | 11x | $46.91 | -28% |
| Current | 15x | $64.80 | — |
| Forward | 16x | $64.80 | — |
Historical ranges are pointers, not guarantees.
MTH's PE is in its expensive range at 15x. Analysts expect earnings to fall, which would put today's price at 16x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MTH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect MTH's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.93 | -12% |
| Q3 2026 | $4.46 | -40% |
| Q2 2026 | $4.81 | -45% |
| Q1 2026 | $5.48 | -45% |
| Q4 2025 | $6.35 | -41% |
| Q3 2025 | $7.49 | -32% |
| Q2 2025 | $8.77 | -23% |
| Q1 2025 | $9.88 | -7.8% |
| Q4 2024 | $10.72 | +7.6% |
MTH has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MTH Quarterly Revenue
MTH and LCID do not have enough comparable growth data to identify a winner.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 23% | N/A |
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$35.3M | +$69M |
| Q2 2026 | $183.9M | +2552% |
| Q1 2026 | $97M | +$145.2M |
| Q4 2025 | $238.1M | +$345.1M |
| Q3 2025 | -$104.3M | -$4.3M |
| Q2 2025 | $6.9M | +$131.8M |
| Q1 2025 | -$48.2M | -164% |
| Q4 2024 | -$107M | +$4.4M |
MTH has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -1M shares |
| 1 year | -8.5% | -6.1M shares |
| 3 years | -12% | -9M shares |
| 5 years | -15% | -11.3M shares |
| Available history | -16% | -12.7M shares |
MTH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $55M |
| Q2 2026 | $100M |
| Q1 2026 | $130M |
| Q4 2025 | $150M |
| Q3 2025 | $55M |
| Q2 2025 | $45M |
| Q1 2025 | $45M |
| Q4 2024 | $40M |
MTH spent $435M buying back its own shares over the past year, up 135% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.6x | Very low |
MTH's net debt is about 2.8 years of its operating earnings (EBITDA), up from 1.5 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 46.3 | Neutral |
MTH's weekly RSI is 46 (neutral) and its Stochastic is 46 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MTH PE vs Consumer Cyclical Sector
| Metric | MTH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 19% below |
| PE % | 98 | 47 | 51 pts above |
MTH is trading at 15x earnings, a 19% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.5 | 2% above |
| 20 week MA | $68.4 | 5.3% below |
| 50 week MA | $69.1 | 6.2% below |
| 100 week MA | $70.4 | 7.9% below |
| 200 week MA | $73.4 | 12% below |
MTH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.7 | $44.2 | +44% |
| 2021 | $44.2 | $58.5 | +32% |
| 2022 | $58.5 | $46.1 | -21% |
| 2023 | $46.1 | $87.1 | +89% |
| 2024 | $87.1 | $77.1 | -12% |
| 2025 | $77.1 | $66.8 | -13% |
| 2026 YTD | $66.8 | $64.8 | -3% |
MTH has the edge over LCID on returns for 2026, with the stronger performance.